Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin Full Text
BMC Infectious Diseases, 07/20/2012
Clinical Article
Ramirez JA et al. – Switch therapy outcomes in hospitalized patients with CAP receiving initial IV therapy with tigecycline are comparable to those of patients receiving initial IV therapy with levofloxacin. These data support the use of IV tigecycline in hospitalized patients with CAP when the switch therapy approach is considered.



